Period 1 | Period 2 | ||
---|---|---|---|
Drug | No. | Drug | No. |
Antibiotics | 339 (53.1%) | Antibiotics | 228 (21.5%) |
Cephalosporin | 101 | Cephalosporin | 83 |
Quinolone | 89 | Quinolone | 65 |
Macrolide | 42 | Macrolide | 29 |
Penicillin | 38 | Penicillin | 21 |
Lincosamide | 23 | Nitroimidazole | 7 |
Nitroimidazole | 17 | Lincosamide | 6 |
Aminoglycosides | 7 | Glycopeptide | 9 |
Glycopeptide | 7 | Fosfomycin | 1 |
Fosfomycin | 6 | Antifungal | 1 |
Antifungal | 4 | Tetracycline | 1 |
Antituberculotic | 4 | Antituberculotic | 2 |
Sulfa | 1 | Other | 3 |
Chinese patent medicine | 91 (14.2%) | Chinese patent medicine | 171 (16.1%) |
Cardiovascular | 34 (5.3%) | NSAIDs | 154 (14.5%) |
CCBs | 5 | Conventional | 139 |
ACEI/ARB | 5 | Cox-2 inhibitor | 15 |
Antilipemic | 23 | Cardiovascular | 89 (8.4%) |
Antiarrhythmic drugs | 1 | Antihypertensive | 37 |
NSAIDs | 31 (4.9%) | Antilipemic | 13 |
Conventional | 25 | Antiarrhythmic drugs | 14 |
Cox-2 inhibitor | 6 | Nitrates | 16 |
CNS drugs | 17 (2.7%) | Cardiotonic | 9 |
Antidepressant | 7 | Antithrombotic | 43 (4.1%) |
Improving CNS metabolism | 4 | CNS drugs | 51 (4.8%) |
CNS muscle relaxant | 2 | Antidepressant | 21 |
Anticonvulsant | 4 | Improving CNS metabolism | 2 |
Antiviral | 16 (2.5%) | CNS muscle relaxant | 4 |
Gastrointestinal | 15 (2.4%) | Anticonvulsant | 3 |
PPI | 6 | Other CNS drug | 21 |
Others | 9 | Endocrine | 37 (3.5%) |
Immunoregulation | 11 (1.7%) | Gastrointestinal | 34 (3.2%) |
BAs | 11 (1.7%) | PPI | 20 |
Cytotoxicity | 7 (1.1%) | Others | 14 |
Respiratory | 4 (0.6%) | Opioid | 26 (2.5%) |
Antithrombotic | 4 (0.6%) | BAs | 17 (1.6%) |
Endocrine | 3 (0.5%) | Antiviral | 16 (1.5%) |
Hormone | 2 (0.3%) | Cytotoxicity | 15 (1.4%) |
Others | 54 (8.5%) | Diuretic | 15 (1.4%) |
Hormone | 15 (1.4%) | ||
Antigout | 11 (1.0%) | ||
Respiratory | 6 (0.6%) | ||
Immunoregulation | 5 (0.5%) | ||
Others | 127 (12.0%) |